Home | Business News | Browse by Publication | P | PR Newswire

PCA3Plus(TM) the Next Generation Genetic Test for Prostate Cancer Risk: Exclusively from Bostwick Laboratories, Inc.

Publication: PR Newswire
Publication Date: 04-MAY-06
Format: Online
Delivery: Immediate Online Access

Article Excerpt
RICHMOND, Va., May 4 /PRNewswire/ -- Bostwick Laboratories, Inc. announces the immediate availability of PCA3Plus(TM), a urine-based genetic test for prostate cancer risk, exclusively from Bostwick Laboratories, Inc.

PCA3Plus(TM) detects PCA3, a specific gene that is highly expressed in prostate cancer. No other human tissues express PCA3.

"We are...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from PR Newswire
Tucows Reports First Quarter Fiscal 2006 Results., May 04, 2006
FoxHollow Technologies Reports First Quarter Revenues More Than Double..., May 04, 2006
MEDRAD Installs 5,000th Stellant(R) CT Injection System., May 04, 2006
Tellabs Presentation at the 2006 Growth Stock Conference to be Webcast..., May 04, 2006
Memry Corporation Third Fiscal Quarter Revenues Up 10% to $14M; Net In..., May 04, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.